Pharmacosmos Adopts Ennov to Support Quality/GxP Operations

January 19, 2021

Ennov are pleased to announce that the Danish pharmaceutical company Pharmacosmos has implemented Ennov Doc and Ennov Training for the management of their global Quality and GxP documentation. Following the installation, configuration and validation of the software, the system was officially put into production in August 2020 and is being used by approximately 400 total users across all locations (Denmark, US, UK, Ireland, Germany, Sweden and Norway). Pharmacosmos will now turn their attention to the implementation of Ennov QMS to support their quality and GxP processes.


“We are very proud to add Pharmacosmos to the growing list of satisfied Ennov customers,” says CEO Olivier Pâris. “Our teams worked very well together which was the key to the successful Go Live.”


“We are very excited having implemented our new electronic document and quality management system using Ennov throughout Pharmacosmos,” says Flemming Simonsen (Director GxP System Compliance). “It makes our daily handling and signing of documents much faster, reduces the use of paper and eliminates signing documents by hand.”


About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

Pharmacosmos has subsidiaries in US, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.


About Ennov

Ennov provides the most intuitive, comprehensive, and cost-effective suite of software solutions for the life sciences industry. From leading pharmaceutical companies to emerging biotechnology companies, we proudly serve over 200 companies and 150,000 users around the world. Our solutions are designed and built to support the entire Life Sciences R&D continuum including Clinical, Regulatory, Quality, Pharmacovigilance and Commercial. Ennov is headquartered in Paris and has offices in the US and UK. For more information about Ennov, please see .

Share :


Register for free to access to our library of exclusive content!

Highlight Post

Recent Posts